{"id":55348,"date":"2026-09-14T07:39:27","date_gmt":"2026-09-14T07:39:27","guid":{"rendered":"https:\/\/www.theisn.org\/?p=55348"},"modified":"2026-09-14T07:49:37","modified_gmt":"2026-09-14T07:49:37","slug":"isn-journal-editorial-selections-6","status":"publish","type":"post","link":"https:\/\/www.theisn.org\/blog\/2026\/09\/14\/isn-journal-editorial-selections-6\/","title":{"rendered":"ISN\u00a0Journal\u00a0editorial selections\u00a0\u00a0"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]<\/p>\n<h3><i><span data-contrast=\"none\">Kidney International<\/span><\/i><span data-contrast=\"none\">\u00ae\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335557856&quot;:16777215,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/h3>\n<p><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00473-4\/fulltext\" target=\"_blank\" rel=\"noopener\"><b><span data-contrast=\"none\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-55349\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/09\/KI-VA-300x169.jpg\" alt=\"\" width=\"440\" height=\"248\" srcset=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/09\/KI-VA-400x225.jpg 400w, https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/09\/KI-VA-367x206.jpg 367w\" sizes=\"(max-width: 440px) 100vw, 440px\" \/><\/span><\/b><\/a><\/p>\n<p><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00473-4\/fulltext\" target=\"_blank\" rel=\"noopener\"><b><span data-contrast=\"none\">Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis<\/span><\/b><\/a><b><span data-contrast=\"none\">\u00a0<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335557856&quot;:16777215,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Patients receiving hemodialysis are especially vulnerable to\u00a0respiratory syncytial virus\u00a0(RSV), but vaccine responses in this group are poorly understood.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">In a small observational study, the RSV vaccine\u00a0Arexvy\u00a0produced robust antibody and cellular immune responses, although antibody levels rose more slowly than in people with normal kidney function.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Arexvy\u00a0elicited robust immune responses in patients receiving hemodialysis, although antibody responses were delayed.\u00a0Longer dialysis duration was associated with weaker antibody responses.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3><i><span data-contrast=\"none\">Kidney International Reports\u00ae<\/span><\/i><i><span data-contrast=\"auto\">\u202f<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/h3>\n<p><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02924-4\/fulltext\" target=\"_blank\" rel=\"noopener\"><b><span data-contrast=\"none\">IgAN in South Asia<\/span><\/b><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">IgA nephropathy (IgAN) is an underrecognized cause of chronic kidney disease in South Asia, where data and access to newer treatments\u00a0remain\u00a0limited.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Available studies suggest\u00a0relatively poor\u00a0outcomes, with 17% to 37% of patients experiencing major kidney function decline or kidney failure within 12 to 36 months.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The editorial highlights major gaps in regional data\u00a0and calls for stronger local evidence and more\u00a0equitable\u00a0access to effective therapies.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3><i><span data-contrast=\"none\">Kidney International\u00a0Case\u00a0Reports\u2122<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/h3>\n<p><strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S3117471X26000385\" target=\"_blank\" rel=\"noopener\">Precision in diagnosis &#8211; KM55 (galactose deficient IgA1) staining in clinically diagnosed cases of systemic lupus\u00a0erythematosus with\u00a0IgA\u00a0nephropathy<\/a>\u00a0<\/strong><\/p>\n<p><span data-contrast=\"auto\">IgA nephropathy and lupus nephritis can have overlapping clinical and biopsy features, making them difficult to distinguish.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">In three patients initially diagnosed with systemic lupus erythematosus and nephritis, KM55 staining\u00a0showed strong positive results\u00a0consistent with IgA nephropathy.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The findings suggest KM55 staining may help improve diagnostic accuracy in challenging cases and support more\u00a0appropriate treatment\u00a0decisions.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Kidney International\u00ae\u202f\u00a0 Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis\u00a0\u00a0 Patients receiving hemodialysis are especially vulnerable to\u00a0respiratory syncytial virus\u00a0(RSV), but vaccine responses in this group are poorly understood.\u00a0\u00a0 In a small observational study, the RSV vaccine\u00a0Arexvy\u00a0produced robust antibody and cellular immune responses, although antibody levels rose [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":29446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[98,36],"tags":[209,253,391],"class_list":["post-55348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-journals","category-news","tag-hemodialysis","tag-iga-nephropathy","tag-lupus-nephritis"],"featured_image_src":{"landsacpe":["https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/03\/The-ISN-Journals-3-1024x445.jpg",1024,445,true],"list":["https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/03\/The-ISN-Journals-3-366x246.jpg",366,246,true],"medium":["https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/03\/The-ISN-Journals-3-300x200.jpg",300,200,true],"full":["https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/03\/The-ISN-Journals-3.jpg",1024,681,false]},"_links":{"self":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/posts\/55348"}],"collection":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/comments?post=55348"}],"version-history":[{"count":2,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/posts\/55348\/revisions"}],"predecessor-version":[{"id":55351,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/posts\/55348\/revisions\/55351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/media\/29446"}],"wp:attachment":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/media?parent=55348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/categories?post=55348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/tags?post=55348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}